Literature DB >> 8808124

Cardiovascular disease after renal transplantation.

B L Kasiske1, C Guijarro, Z A Massy, M R Wiederkehr, J Z Ma.   

Abstract

Although cardiovascular disease is a major cause of morbidity and mortality after renal transplantation, its pathogenesis and treatment are poorly understood. We conducted separate analyses of risk factors for ischemic heart disease, cerebral, and peripheral vascular disease after 706 renal transplants, all of which functioned for at least 6 months. We used Cox proportional hazards analysis to examine the effects of multiple pretransplant and posttransplant risk factors and included time-dependent variables measured at 3, 6, and 12 months, and annually to last follow-up at 7.0 +/- 4.2 yr. The independent relative risk (RR) of diabetes was 3.25 for ischemic heart disease, 3.21 for cerebral vascular disease, and 28.18 peripheral vascular disease (P < 0.05). The RR of each acute rejection episode was 1.40 for ischemic heart disease and 1.24 for cerebral vascular disease. Among serum lipid levels, high-density lipoprotein cholesterol was the best predictor of ischemic heart disease (RR = 0.80 for each 10 mg/dL). Posttransplant ischemic heart disease was strongly predictive of cerebral (5.80) and peripheral vascular disease (5.22), whereas ischemic heart disease was predicted by posttransplant cerebral (8.25) and peripheral vascular disease (4.58). Other risk factors for vascular disease included age, gender, cigarette smoking, pretransplant splenectomy, and serum albumin. Hypertension and low-density lipoprotein cholesterol had no effect, perhaps because of aggressive pharmacologic treatment. Thus, the incidence of cardiovascular disease continues to be high after renal transplantation, and multiple risk factors suggest a number of possible strategies for more effective treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808124     DOI: 10.1681/ASN.V71158

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  78 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.

Authors:  S Türk; A Yildiz; T Tükek; V Akkaya; U Aras; A Türkmen; A R Uras; M S Sever
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant.

Authors:  Jeffrey J Gaynor; Gaetano Ciancio; Giselle Guerra; Junichiro Sageshima; Lois Hanson; David Roth; Michael J Goldstein; Linda Chen; Warren Kupin; Adela Mattiazzi; Lissett Tueros; Sandra Flores; Luis J Barba; Adrian Lopez; Jose Rivas; Phillip Ruiz; Rodrigo Vianna; George W Burke
Journal:  Diabetologia       Date:  2014-11-01       Impact factor: 10.122

4.  Long-Term Impact of Different Immunosuppressive Drugs on QT and PR Intervals in Renal Transplant Patients.

Authors:  Baris Ikitimur; Kahraman Cosansu; Bilgehan Karadag; Huseyin Altug Cakmak; Burcak Kilickiran Avci; Emre Erturk; Nurhan Seyahi; Zeki Ongen
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

Review 5.  A practical guide to the management of hypertension in renal transplant recipients.

Authors:  A J Olyaei; A M deMattos; W M Bennett
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

6.  Pretransplant physical activity predicts all-cause mortality in kidney transplant recipients.

Authors:  Sylvia E Rosas; Peter P Reese; Yonghong Huan; Cataldo Doria; Philip T Cochetti; Alden Doyle
Journal:  Am J Nephrol       Date:  2011-12-10       Impact factor: 3.754

7.  Unusual pattern of dyslipidemia in children receiving steroid minimization immunosuppression after renal transplantation.

Authors:  Keith K Lau; Daniel J Tancredi; Richard V Perez; Lavjay Butani
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

8.  Stress testing in patients with chronic kidney disease: The need for ancillary markers for effective risk stratification and prognosis.

Authors:  Sripal Bangalore
Journal:  J Nucl Cardiol       Date:  2015-08-22       Impact factor: 5.952

Review 9.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

10.  Prognostic impact of SPECT-MPI after renal transplantation.

Authors:  Wael Abuzeid; Robert M Iwanochko; Xuesong Wang; S Joseph Kim; Mansoor Husain; Douglas S Lee
Journal:  J Nucl Cardiol       Date:  2016-09-23       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.